<DOC>
	<DOCNO>NCT00002428</DOCNO>
	<brief_summary>To evaluate safety immunogenicity combination microparticulate monovalent HIV-1 MN synthetic branch peptide candidate vaccine oral administration monovalent HIV-1 MN synthetic branch peptide vaccine alum intramuscular administration intermediate high risk HIV-negative volunteer .</brief_summary>
	<brief_title>A Phase I/II Safety Immunogenicity Trial UBI Microparticulate Monovalent ( HIV-1 MN ) Branched Peptide Vaccine HIV-1 Seronegative Human Subjects</brief_title>
	<detailed_description>Volunteers receive one two schedule vaccine placebo administer day 0 , 28 , 168 . Specifically , group 1 receive oral microparticulate monovalent vaccine 3 consecutive day day 0 , 1 , 2 , 28 , 29 , 30 , intramuscular monovalent vaccine give day 168 . Group 2 receive intramuscular vaccine first , day 0 , follow oral form give day 28 , 29 , 30 168 , 169 , 170 . Volunteers follow 1 year .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria Volunteers must : Normal history physical exam . HIV negativity . CD4 count &gt; = 400 cells/mm3 . Intermediate high risk sexual behavior history injection drug use within 12 month prior study entry . Normal urine dipstick esterase nitrite . Exclusion Criteria Coexisting Condition : Volunteers follow symptoms condition exclude : Active tuberculosis . Occupational responsibility would prevent completion study . Volunteers follow prior condition exclude : History immunodeficiency , chronic illness , autoimmune disease , use immunosuppressive medication . Psychiatric , medical , substance abuse problem within past 6 month would affect ability participate study . History anaphylaxis serious adverse reaction vaccine . History inflammatory gastrointestinal disease , celiac disease , intestinal malignancy . Acute gastroenteritis gastrointestinal surgery within past 12 month . Prior Medication : Excluded : Live attenuated vaccine within past 60 day . Illicit experimental agent within past 30 day . Intermediate high risk sexual behavior . Injection drug use within past 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 1996</verification_date>
	<keyword>Vaccines , Synthetic</keyword>
	<keyword>HIV-1</keyword>
	<keyword>HIV Envelope Protein gp120</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>